Top

BMC Complementary Medicine and Therapies

Published in:

Open Access 01-12-2021 | Ampicillin | Research article

Characterization of the antibacterial activity from ethanolic extracts of the botanical, Larrea tridentata

Authors: Tiffany Turner, Guillermo Ruiz, Johanne Gerstel, Jeffrey Langland

Published in: BMC Complementary Medicine and Therapies | Issue 1/2021

Abstract

Background

β-lactam antibiotics are a class of broad-spectrum antibiotics consisting of all antibiotic agents that contain a β-lactam ring in their molecular structures. β-lactam antibiotics are only known to be isolated from fungi (e.g. Acremonium chrysogenum, Penicillium chrysogenum and Aspergillus nidulans) and bacteria (e.g. Streptomyces clavuligerus). We have shown that botanical extracts prepared from Larrea tridentata have strong antimicrobial activity against several bacteria, including members of Staphylococcus and Streptococcus genera.

Methods

Through resistance studies, inhibitor assays, and ELISA testing, we demonstrated L. tridentata extracts may contain a β-lactam type antibiotic activity.

Results

Based on the estimated β-lactam concentration within the extract, the antimicrobial activity of the L. tridentata extract was approximately 2000–8000-fold greater against Staphylococcus as compared to other β-lactams, penicillin or ampicillin. In the L. tridentata extract, this increased activity was found to be associated with the likely presence of a cofactor leading to increased potentiation of the β-lactam activity. This potentiation activity was also observed to enhance the activity of exogenously added natural penicillin antibiotics.

Conclusions

Although constituents were not isolated in this study, the results obtained strongly support the presence of β-lactam type antibiotic activity and antibiotic potentiation activity present in ethanolic extracts prepared from L. tridentata.

Kardos N, Demain AL. Penicillin: the medicine with the greatest impact on therapeutic outcomes. Appl Microbiol Biotechnol. 2011;92(4):677–87. https://doi.org/10.1007/s00253-011-3587-6.CrossRefPubMed

Hamed RB, Gomez-Castellanos JR, Henry L, Ducho C, McDonough MA, Schofield CJ. The enzymes of β-lactam biosynthesis. Nat Prod Rep. 2013;30(1):21–107. https://doi.org/10.1039/C2NP20065A.CrossRefPubMed

Cho H, Uehara T, Bernhardt TG. Β-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery. Cell. 2014;159(6):1300–11. https://doi.org/10.1016/j.cell.2014.11.017.CrossRefPubMedPubMedCentral

Snowden R. A comparison of the anti- Staphylococcus aureus activity of extracts from commonly used medicinal plants. J Altern Complement Med. 2014;20(5):375–82. https://doi.org/10.1089/acm.2013.0036.CrossRefPubMed

Favela-Hernández JMJ, García A, Garza-González E, Rivas-Galindo VM, Camacho-Corona MR. Antibacterial and Antimycobacterial Lignans and flavonoids from Larrea tridentata. Phytother Res. 2012;26(12):1957–60. https://doi.org/10.1002/ptr.4660.CrossRefPubMed

Gomez-Corona R. Natural compounds from Mexican medicinal plants as potential drug leads for anti-tuberculosis drugs. An Acad Bras Cienc. 2017;89(1):31–43. https://doi.org/10.1590/0001-3765201720160298.CrossRef

Favela-Hernández J, Clemente-Soto A, Balderas-Rentería I, Garza-González E, Camacho-Corona M. Potential mechanism of action of 3′-Demethoxy-6-O-demethyl-isoguaiacin on methicillin resistant Staphylococcus aureus. Molecules. 2015;20(7):12450–8. https://doi.org/10.3390/molecules200712450.CrossRefPubMedPubMedCentral

García JE. Anthelmintic efficacy of hydro-methanolic extracts of Larrea tridentata against larvae of Haemonchus contortus. Trop Anim Health Prod. 2018;50(5):1099–105. https://doi.org/10.1007/s11250-018-1535-5.CrossRefPubMed

Bashyal B, Li L, Bains T, Debnath A, LaBarbera DV. Larrea tridentata: a novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri. PLoS Negl Trop Dis. 2017;11(8):e0005832. https://doi.org/10.1371/journal.pntd.0005832.CrossRefPubMedPubMedCentral

10.

CDC. Antibiotic resistance threats in the United States. 2013. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed June 2021.

11.

Zhang M, Kong X, Zheng J, Wan JB, Wang Y, Hu Y, et al. Research and development of antibiotics: insights from patents and citation network. Expert Opin Ther Pat. 2016;26(5):617–27. https://doi.org/10.1517/13543776.2016.1167877.CrossRefPubMed

12.

Shahid M. Β-lactams and Β-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update. Crit Rev Microbiol. 2009;35(2):81–108. https://doi.org/10.1080/10408410902733979.CrossRefPubMed

13.

Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect. 2005;11:4–16. https://doi.org/10.1111/j.1469-0691.2005.01238.x.CrossRefPubMedPubMedCentral

14.

Neu HC, Fu KP. Clavulanic acid, a novel inhibitor of β-lactamases. Antimicrob Agents Chemother. 1978;14(5):650–5. https://doi.org/10.1128/AAC.14.5.650.CrossRefPubMedPubMedCentral

15.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests. Twenty-second informational supplement. CLIS. 2014;32(3):M100–S22.

16.

Ruiz G, Turner T, Nelson E, Sparks L, Langland J. Development of resistance to antimicrobial botanicals. J Evol Health. 2017;2(2):3. https://doi.org/10.15310/2334-3591.1065.

17.

Hamed RB, Gomez-Castellanos JR, Henry L, Ducho C, McDonnough MA, Schofield CJ. The enzymes of β-lactam biosynthesis. Nat Prod Rep. 2012. https://doi.org/10.1039/c2np20065a.

18.

Shimizu M, Shiota S, Mizushima T, Ito H, Hatano T, Yoshida T, et al. Marked potentiation of activity of β--lactams against methicillin-resistant Staphylococcus aureus by Corilagin. Antimicrob Agents Chemother. 2001;45(11):3198–201. https://doi.org/10.1128/AAC.45.11.3198-3201.2001.CrossRefPubMedPubMedCentral

19.

Shiota S. Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of β-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol. 2004;48(1):67–73. https://doi.org/10.1111/j.1348-0421.2004.tb03489.x.CrossRefPubMed

Title: Characterization of the antibacterial activity from ethanolic extracts of the botanical, Larrea tridentata
Authors: Tiffany Turner
Guillermo Ruiz
Johanne Gerstel
Jeffrey Langland
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Ampicillin
Antibiotic
Penicillins
Published in: BMC Complementary Medicine and Therapies / Issue 1/2021
Electronic ISSN: 2662-7671
DOI: https://doi.org/10.1186/s12906-021-03344-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Characterization of the antibacterial activity from ethanolic extracts of the botanical, Larrea tridentata

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals

Effect of Shenkang on renal fibrosis and activation of renal interstitial fibroblasts through the JAK2/STAT3 pathway

The effect of lutein and Urtica dioica extract on in vitro production of embryo and oxidative status in polycystic ovary syndrome in a model of mice

Luteolin ameliorates lipopolysaccharide-induced microcirculatory disturbance through inhibiting leukocyte adhesion in rat mesenteric venules

A randomised controlled trial of expressive arts-based intervention for young stroke survivors

Antimicrobial activity of medicinal plants used for urinary tract infections in pastoralist community in Ethiopia